Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
03/2018 - 06/2018
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
according to guideline
OECD Guideline 402 (Acute Dermal Toxicity)
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:

Test material

Constituent 1
Chemical structure
Reference substance name:
EC Number:
EC Name:
Cas Number:
Molecular formula:
Test material form:
liquid: viscous
Specific details on test material used for the study:
Test item No.: 13/0241-4
Batch identification: 16315004
CAS No.: 93940-97-7
Purity: 96.1 area-% (mixture of isomers)
Homogeneity: The test item was homogeneous by visual inspection.
Storage stability: The stability of the test item under storage conditions over the study period was guaranteed by the sponsor, and the sponsor holds this responsibility.
Expiry date: May 01, 2019
Storage conditions: Ambient (RT)
Physical state/ color: Liquid / yellowish, clear
Density [g/mL]: 0.986 (determined by Bioassay Laboratories)

Test animals

Details on test animals or test system and environmental conditions:
Age on day 0: Young adult animals (male animals approx. 8 weeks, female animals approx. 12 weeks)
Body weight on day 0: Animals of comparable weight (± 20% of the mean weight)

Room temperature / relative humidity: The animals were housed in fully air-conditioned rooms. Central air-conditioning guaranteed a range of 22°C  3°C for temperature and of 30 – 70% for relative humidity. There were no deviations from these ranges, which influenced the results of the study.
Air changes per hour: Approx. 10
Day / night rhythm: 12 h / 12 h (6.00 a.m. – 6.00 p.m. / 6.00 p.m. – 6.00 a.m.)
Type of cage: Makrolon cage, type III
Number of animals per cage: Single housing
Feeding: VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany, ad libitum
Drinking water: Tap water ad libitum
Bedding: H 15005-29; Ssniff, Spezialdiäten GmbH (Experimental Animal Diets Inc., 59494 Soest, Germany)
Enrichment: Wooden gnawing blocks (Type NGM E-022) ; ABEDD® LAB & VET Service GmbH, Hasnerstraße 84/6; 1160 Wien – Austria

Administration / exposure

Type of coverage:
unchanged (no vehicle)
Details on dermal exposure:
Route of application: Single application to the clipped skin (dorsal and dorsolateral parts of the trunk); covering of the application site with a semi-occlusive dressing* for 24 hours. Afterwards removal of the semi-occlusive dressing, rinsing of the application site with warm water
Application area: About 40 cm² (corresponds to at least 10% of the body surface)
Duration of exposure:
24 hours
limit dose: 2000 mg/kg bw
No. of animals per sex per dose:
Details on study design:
Observation period: 14 days

Body weight determination: Individual body weights shortly before application (day 0), weekly thereafter and on the last day of observation.

Clinical observations: Clinical signs for each animal were recorded several times on the day of application and at least once during each workday thereafter.

Scoring of skin findings: Individual readings 30 – 60 minutes after removal of the semi-occlusive dressing (day 1), weekly thereafter /several times until the last day of observation / and on the last day of observation.

Mortality: A check for any dead or moribund animals was made at least once each workday, these records are archived by Bioassay.

Pathology: Necropsy with gross-pathology examination was performed on the last day of the observation period after sacrifice by CO2-inhalation in a chamber with gradually increasing concentrations.

Results and discussion

Effect levels
Dose descriptor:
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
No mortality occurred.
Clinical signs:
other: Systemic effects: No systemic clinical signs were observed during clinical examination in male and female. Local effects: Male: moderate erythema (grade 2) was seen in four male animals from study day 1 until study day 3 and persisted in one of these ani
Gross pathology:
No macroscopic pathologic abnormalities were noted in any animal examined on the last day of observation (5 males and 5 females).

Applicant's summary and conclusion

In an acute dermal toxicity study (Limit Test), young adult Wistar rats (5 males and 5 females) were dermally exposed to a single dose of 2000 mg/kg bw of the undiluted test item 3-[[3-[[(2-cyanoethyl)amino]methyl]-3,5,5- trimethylcyclohexyl]amino]propiononitrile to the clipped application site (dorsal and dorso-lateral parts of the trunk and covered by semi-occlusive dressing during the 24-hour exposure period. The application area comprised at least 10% of the total body surface. The animals were observed for 14 days.
- No mortality occurred
- No signs of systemic toxicity were observed
- The following test item-related local skin effects were recorded during the course of the study, local effects occurred within 10 days after application:
- Well-defined erythema (grade 2)
- Incrustations
- Scaling
- All animals gained weight in a normal range throughout the study period.
- No macroscopic pathologic abnormalities were noted in any animal examined at the end of the study (5 males and 5 females).
Accordingly, the acute dermal median lethal dose (LD50) was determined to be LD50, dermal, rat > 2000 mg/kg bw
Executive summary:

Under the conditions of this study the median lethal dose (LD50) of 3-[[3-[[(2-cyanoethyl)amino]methyl]-3,5,5- trimethylcyclohexyl]amino]propiononitrile after dermal application was found to be greater than 2000 mg/kg bw in male and female rats.